SG acquires AstraZeneca's Evusheld

Evusheld is a long-acting antibody candidate for COVID-19 treatment.

The government of Singapore has signed a purchase agreement with AstraZeneca to deliver Evusheld, its long-acting antibody (LAAB) combination candidate, for the treatment of COVID-19.

The supply will arrive in Singapore by year-end.

"Evusheld provides healthcare professionals and patients in Singapore with a new option to fight the virus. Additionally, Evusheld will provide another prevention option for high-risk populations, alongside vaccines, including for people who are immunocompromised and unable to develop the needed degree of protective response following COVID-19 vaccination," AstraZeneca Singapore Country President Vinod Narayanan said.

A Phase III trial showed an 88% reduced risk of severe COVID-19 or death when patients with mild-to-moderate COVID-19 were treated within three days of symptom onset. AstraZeneca has this week received Emergency Use Authorization for Evusheld from the US Food and Drug Administration for the prevention of COVID-19 and has filed for regulatory approvals in other countries.

Follow the link for more news on

AstraZeneca

Singapore COVID-19

If you've been wondering whether SBR could work for your company — yes, probably.

A lot of the companies we partner with started as readers. They'd been following our coverage for a while, saw their own customers and competitors in it, and eventually asked the obvious question: could we do something with you? The answer is usually yes. The shape of it depends on what you're trying to do.

The options are broader than most people assume — thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. Some partners use one channel; most use a mix. We figure out the right combination by starting with your brief, not with our rate card.

So if the question has been on your mind, here's the easy way to ask it.

We'll tell you honestly whether we can help, and how. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia